Prosecution Insights
Prosecution Insights
36 pending office actions • 21 art units • 35 examiners • 0 of 36 (0%) have an AI response strategy ready • 31 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 4 (11%) |
| §103 only | 7 (19%) |
| §102 only | 2 (6%) |
| §112 only | 2 (6%) |
| Double-patenting only | 3 (8%) |
| Double-patenting + other | 2 (6%) |
| Multi-statute (no §101) | 14 (39%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAU, JONATHAN S | 2 | 63.9% | -18.1% |
| GALSTER, SAMUEL LEONARD | 1 | 52.3% | +41.7% |
| MATTHEWS, WILLIAM H | 1 | 66.7% | +21.6% |
| KUO, JONATHAN T | 1 | 72.5% | +27.7% |
| NAH, JONGBONG | 1 | 76.3% | +16.3% |
| OKEKE, IZUNNA | 1 | 81.8% | +15.6% |
| RICCI, CRAIG D | 1 | 53.5% | +52.6% |
| MOORE, SUSANNA | 1 | 67.9% | +31.6% |
| CHAO, ALLEN | 1 | 66.7% | +0.0% |
| CHO, DAVID H | 1 | 37.5% | +73.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18853930 | DEVICES, SYSTEMS AND METHODS FOR SECURING COMMUNICATION INTEGRITY | OKEKE, IZUNNA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000865 | DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION | KIM, TAEYOON | 49d overdue |
| 18526386 | SYSTEMS AND METHODS FOR INDIVIDUALIZED TARGETING OF DEEP BRAIN STIMULATION | SHOULDERS, ANNIE LEE | 17d overdue |
| 18288503 | Handheld Auscultation Systems, Devices, and Methods | GHAND, JENNIFER LEIGH-STEWAR | 16d overdue |
| 18531138 | Systems, Devices and Methods for Noninvasively Determining Jugular Venous Pressure and/or Associated Metrics | OGLES, MATTHEW ERIC | 15d overdue |
| 18025750 | MULTI-MODAL SYSTEM AND METHOD FOR TRACKING RESPIRATORY HEALTH | DOWNEY, JOHN R | 13d |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 48d |
| 18276736 | Diruthenium Catalyst Compositions and Synthetic Processes Related Thereto | BAKSHI, PANCHAM | 78d |
| 18993727 | RECORDING AND RECOVERY OF SIGNALS DURING STIMULATION | KUO, JONATHAN T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19380466 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | GALSTER, SAMUEL LEONARD | — |
| 19304178 | Cardiac Valve Leaflet Enhancer Devices and Systems | MATTHEWS, WILLIAM H | — |
| 18993727 | RECORDING AND RECOVERY OF SIGNALS DURING STIMULATION | KUO, JONATHAN T | — |
| 18961390 | Systems and Methods for Correcting Intravoxel and/or Voxel Inhomogeneity | NAH, JONGBONG | — |
| 18853930 | DEVICES, SYSTEMS AND METHODS FOR SECURING COMMUNICATION INTEGRITY | OKEKE, IZUNNA | — |
| 18853643 | Indolium Compounds for Treating Cancer | RICCI, CRAIG D | — |
| 18673818 | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto | MOORE, SUSANNA | — |
| 18702922 | TREATMENT OF VIRUSES WITH ANTIVIRAL NUCLEOSIDES | CHO, DAVID H | — |
| Art Unit | Apps |
|---|---|
| 1693 | 4 |
| 3791 | 2 |
| 1626 | 2 |
| 3792 | 2 |
| 3774 | 1 |
| 2408 | 1 |
| 1624 | 1 |
| 1634 | 1 |
| 1691 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19380466 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | GALSTER, SAMUEL LEONARD | 1693 | §103 | Final Rejection | — | Pending | Nov 05, 2025 |
| 19304178 | Cardiac Valve Leaflet Enhancer Devices and Systems | MATTHEWS, WILLIAM H | 3774 | Other | Non-Final OA | — | Pending | Aug 19, 2025 |
| 18993727 | RECORDING AND RECOVERY OF SIGNALS DURING STIMULATION | KUO, JONATHAN T | — | §102§103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18961390 | Systems and Methods for Correcting Intravoxel and/or Voxel Inhomogeneity | NAH, JONGBONG | — | §103 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18853930 | DEVICES, SYSTEMS AND METHODS FOR SECURING COMMUNICATION INTEGRITY | OKEKE, IZUNNA | 2408 | §102 | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18853643 | Indolium Compounds for Treating Cancer | RICCI, CRAIG D | — | §102 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18673818 | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto | MOORE, SUSANNA | 1624 | DP | Non-Final OA | — | Pending | May 24, 2024 |
| 18709395 | Prodrugs of Neurosteroid Analogs and Uses Thereof | CHAO, ALLEN | — | DP | Non-Final OA | — | Pending | May 10, 2024 |
| 18702922 | TREATMENT OF VIRUSES WITH ANTIVIRAL NUCLEOSIDES | CHO, DAVID H | — | §103§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18612453 | SYSTEMS AND METHODS FOR DRIVING NEURAL ACTIVITY TO CONTROL BRAIN SIGNALING AND GENE EXPRESSION | DORNA, CARRIE R | 3791 | §112DP | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18292483 | Methods of Improving Therapeutic Efficacy of Mesenchymal Stromal Cells for Treatment of Osteoarthritis | KASAYAN, KATRIEL BARCELLANO | 1634 | §101§103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18291630 | PHOSPHATE PRODRUGS OF CANNABINOIDS | RAHMANI, NILOOFAR | 1691 | §102§112 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18580674 | BAK ACTIVATORS, PHARMACEUTICAL COMPOSITIONS, AND USES IN TREATING CANCER | HAVLIN, ROBERT H | 1626 | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579142 | T Cell Receptors (TCR) to Human Papillomavirus Proteins, Compositions, and Uses Thereof | GODDARD, LAURA B | — | §101§102§103§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18572536 | 3-Iodopropyl-1,2,3-Triazol-1-yl, 3-Bromopropyl-1,2,3-Triazol-1-yl, and Derivatives for Uses in Labeling | LEWOCZKO, EVAN MICHAEL | 1612 | DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18542096 | SYSTEMS AND METHODS TO MEASURE OCCLUSION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS | ORANGE, DAVID BENJAMIN | — | §102§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18542154 | SYSTEMS, APPARATUSES, AND METHODS TO MEASURE ADHESION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS | JARRETT, LORE RAMILLANO | — | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18531138 | Systems, Devices and Methods for Noninvasively Determining Jugular Venous Pressure and/or Associated Metrics | OGLES, MATTHEW ERIC | 3791 | §101§103§112 | Non-Final OA | 15d overdue | Pending | Dec 06, 2023 |
| 18526386 | SYSTEMS AND METHODS FOR INDIVIDUALIZED TARGETING OF DEEP BRAIN STIMULATION | SHOULDERS, ANNIE LEE | 3794 | §103§112 | Non-Final OA | 17d overdue | Pending | Dec 01, 2023 |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 3792 | §101§103 | Non-Final OA | 48d | Pending | Nov 27, 2023 |
| 18561673 | JAK Inhibitors for Managing Conditions in Patients with Down's Syndrome or Other Trisomy | LANDSMAN, ROBERT S | — | §112 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18289868 | ISOLATION AND ANALYSIS OF SINGLE CELLS SECRETING MOLECULES USING HETEROFUNCTIONAL PARTICLES | LUSI, ELLIS FOLLETT | 1677 | §102§112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18288503 | Handheld Auscultation Systems, Devices, and Methods | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §102§103§112 | Non-Final OA | 16d overdue | Pending | Oct 26, 2023 |
| 18287844 | GluN2 Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptors | OTTON, ALICIA L | 1699 | §102§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18285789 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | LAU, JONATHAN S | 1693 | §103 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18276736 | Diruthenium Catalyst Compositions and Synthetic Processes Related Thereto | BAKSHI, PANCHAM | 1623 | §102§103 | Non-Final OA | 78d | Pending | Aug 10, 2023 |
| 18359435 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | LAU, JONATHAN S | 1693 | §103 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18034520 | Modulators of Orphan Nuclear Receptors for Treating Pancreatitis, Glioblastoma, Sarcopenia and Stroke | KUCKLA, ANNA GRACE | 1626 | §103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18025750 | MULTI-MODAL SYSTEM AND METHOD FOR TRACKING RESPIRATORY HEALTH | DOWNEY, JOHN R | 3792 | §101 | Final Rejection | 13d | Pending | Mar 10, 2023 |
| 18111350 | RESPONSE-GUIDED HCV THERAPY | CHANDRAKUMAR, NIZAL S | 1625 | §103§112 | Non-Final OA | — | Pending | Feb 17, 2023 |
| 18041785 | 5'-SUBSTITUTED NUCLEOSIDE MONOPHOSPHATES, PRODRUGS THEREOF, AND USES RELATED THERETO | LEE, HOI YAN NMN | 1693 | §103Other | Non-Final OA | 8d | Pending | Feb 15, 2023 |
| 18000865 | DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION | KIM, TAEYOON | 1631 | §102§103 | Non-Final OA | 49d overdue | Pending | Dec 06, 2022 |
| 17925179 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | — | Pending | Nov 14, 2022 |
| 17921051 | Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation | WARD, PAUL V | 1622 | §112 | Final Rejection | — | Pending | Oct 24, 2022 |
| 17908766 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | WESTERBERG, NISSA M | 1618 | §103 | Final Rejection | 67d overdue | Pending | Sep 01, 2022 |
| 16972800 | Compositions of Transforming Growth Factor-Beta Type III Receptor and Uses for Ossification | REYNOLDS, FRED H | 1658 | §103 | Final Rejection | 51d overdue | Pending | Dec 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial